- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04025528
Pathophysiology of Hypoventilation in Obesity and Effects of Bariatric Intervention (PHOEBI)
Pathophysiology of Hypoventilation in Obesity and Effects of Bariatric Intervention: PHOEBI Study
Breathing is impacted by obesity. Early changes are characterised by significant breathing abnormalities during sleep (a condition called sleep disordered breathing, the most common of which is obstructive sleep apnoea). As the breathing changes worsen in severity, it may result in a rise in carbon dioxide levels during daytime causing a condition called obesity hypoventilation syndrome (OHS). The current treatment for obesity related breathing changes include supportive breathing therapy at night, optimisation of associated medical conditions and weight loss.
Weight management is an important part of obesity treatment. Weight loss strategies such as life-style modification do not always work. Weight loss surgery (bariatric surgery) has been shown to be an effective weight management intervention with long-term results. This study aims to understand breathing changes that occurs due to obesity and their resolution after weight loss surgery. The investigators are aiming to recruit participants with sleep disordered breathing who are currently awaiting bariatric surgery. In particular, the investigators are interested in comparing breathing changes in participants with OHS, who have abnormal regulation of their carbon dioxide levels, and participants with sleep disordered breathing with normal CO2 regulation.
Participants will be recruited through outpatient clinics for sleep disordered breathing. The participants will undergo comprehensive breathing assessments on enrolment including an overnight sleep study. Participants will undergo further daytime breathing assessments before and after their bariatric surgery. End of study will be 6 months after surgery - participants will have a final comprehensive breathing assessment including an overnight sleep study to review resolution of their breathing changes. Depending on the wait list time for the bariatric surgery, it is anticipated that participants will be enrolled in the study for 2 years.
Study Overview
Status
Conditions
Intervention / Treatment
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
London, United Kingdom, SE17EH
- Recruiting
- Guy's and St Thomas' NHS Trust
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients 18 years or older
- BMI > 40
- Patients with significant sleep disordered breathing requiring treatment
- Patient is being assessed for bariatric surgery for either gastric sleeve or gastric bypass surgery
Exclusion Criteria:
- Patients with decompensated hypercapnic respiratory failure (pH< 7.3)
- Chronic hypercapnic respiratory failure due to a cause other than obesity such as neuromuscular, chest wall or airway disease
- Unstable cardiac disease including coronary artery disease and heart failure
- Significant co-morbid psychiatric disease requiring anti-psychotic medications
- Chronic pain syndrome on high dose opioid medications
- Treatment for drug or alcohol addiction
- Cognitive impairment that would prevent informed consent
- Pregnancy
- Need for long-term renal replacement therapy
- Patients who undergo bariatric intervention with gastric balloon or gastric band.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Hypercapnic
Obese patients with daytime hypercapnia
|
Weight loss surgery with either gastric sleeve or gastric bypass surgery
|
|
Eucapnic
Obese patients with normal daytime carbon dioxide levels
|
Weight loss surgery with either gastric sleeve or gastric bypass surgery
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Expiratory flow limitation as measured by forced oscillation testing
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patients has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of expiratory flow limitation at different position including upright, 45 degrees and supine.
We will explore whether expiratory flow limitation can differentiate hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patients has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Degree of change in expiratory flow limitation
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Explore whether the degree of positional change in expiratory flow limitation can differentiate between eucapnic and hypercapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Closing capacity
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of closing capacity at different position including upright, 45 degrees and supine.
We will explore whether expiratory flow limitation can differentiate hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Degree of change in closing capacity
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Explore whether the degree of positional change in closing capacity can differentiate between eucapnic and hypercapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Correlation between closing capacity and expiratory flow limitation
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Compare outcome 1 and 3 to explore whether there is a relationship between expiratory flow limitation and closing capacity
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Intra-abdominal pressure
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
We will measure intra-abdominal pressure and explore whether hypercapnic patients have increased intra-abdominal pressure.
Positional changes will be measured
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Correlation between intra-abdominal pressure, closing capacity and expriatory flow limitation
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Compare outcome 1,3 and 6.
This is a complex multi-compartment model that can differentiate hypercapnia and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Upper airway collapsibility
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of upper airway collapsibility as measure by negative expiratory pressure.
Explore whether there is a relationship between hypercapnic and eucapnic patients depending on degree of upper airway collapsibility
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Lung compliance
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of lung compliance with pressure volume curve including measurements in different positions (upright, 45 degrees and supine)
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Respiratory muscle strength (maximal inspiratory pressure/maximal expiratory)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of inspiratory and expiratory muscle strength
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Respiratory muscle strength (SNIP test)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Measurement of sniff nasal inspiratory pressure
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Daytime neural respiratory drive (para-sternal electromyography measurements)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Daytime neural respiratory drive as measured by parasternal electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Daytime neural respiratory drive (diaphragm electromyography measurements)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Daytime neural respiratory drive as measured by diaphragm electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Nocturnal neural respiratory drive (para-sternal electromyography measurements)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Nocturnal neural respiratory drive as measured by parasternal electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Nocturnal neural respiratory drive (diaphragm electromyography measurements)
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Nocturnal neural respiratory drive as measured by diaphragm electromyography (EMG) measurements can differentiate between hypercapnic and eucapnic patients
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Quality of life post bariatric surgery with SF-36
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Quality of life changes after bariatric surgery more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Quality of life post bariatric surgery with EQ-5D
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Quality of life changes after bariatric surgery more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Symptom change after commencement of medical therapy compared to bariatric surgery measured with Epworth Sleepiness Scale
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Symptom change after bariatric surgery is more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Symptom change after commencement of medical therapy compared to bariatric surgery measured with mMRC (modified medical research council) dypnoea score
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Symptom change after bariatric surgery is more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Symptom change after commencement of medical therapy compared to bariatric surgery measured with Multi-dimensional dyspnoea profile
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Symptom change after bariatric surgery is more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Symptom change after commencement of medical therapy compared to bariatric surgery measured with Severe Respiratory Insufficiency Questionnaire
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Symptom change after bariatric surgery is more than with standard medical therapy
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Changes in healthcare resource usage in OHS patients post bariatric surgery
Time Frame: 6 months pre bariatric surgery and 6 months post bariatric surgery
|
Estimation of healthcare usage cost in the 6 months prior to surgery and 6 months post surgery including medication costs and re-admissions to hospital
|
6 months pre bariatric surgery and 6 months post bariatric surgery
|
|
Improvement in daytime CO2 levels
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Arterial blood gas performed before and after bariatric surgery with improvement in CO2 levels
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Improvement in apnoea-hyponoea index
Time Frame: Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
Patients will have diagnostic sleep study before and after bariatric surgery
|
Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
|
Improvement in mean nocturnal oxygen saturation during sleep
Time Frame: Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
Patients will have diagnostic sleep study before and after bariatric surgery
|
Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
|
Improvement in mean time spent below 90% oxygen saturation during sleep
Time Frame: Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
Patients will have diagnostic sleep study before and after bariatric surgery
|
Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
|
Changes in sleep architecture measured by %slow wave sleep and %REM sleep
Time Frame: Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
Patients will have diagnostic sleep study before and after bariatric surgery
|
Before bariatric surgery on enrolment and 6 months after bariatric surgery
|
|
Improvement in diaphragm function
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Diaphragm thickening will be measured by ultrasound assessment
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Improvement in glycaemic control
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
HbA1C will be measured before and after bariatric surgery
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Spectrum of sleep disordered breathing
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
We will look at sub-group analyses for outcomes 1-29 based on degree of hypoventilation as defined by ERS/ESRS working group
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
|
Choice of bariatric surgery
Time Frame: Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
We will investigate whether outcomes 1-29 is different depending on type of surgery the patient undergoes (gastric bypass compared to gastric sleeve)
|
Measurements on enrolment into study; measurements prior to bariatric surgery (once patient has a surgery date); measurements 2-4 weeks after bariatric surgery; and end of study measurements 6 months after bariatric surgery
|
Collaborators and Investigators
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Anticipated)
Study Completion (Anticipated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Nervous System Diseases
- Respiratory Tract Diseases
- Apnea
- Respiration Disorders
- Sleep Disorders, Intrinsic
- Dyssomnias
- Sleep Wake Disorders
- Overnutrition
- Nutrition Disorders
- Overweight
- Body Weight
- Signs and Symptoms, Respiratory
- Sleep Apnea Syndromes
- Respiratory Insufficiency
- Sleep Apnea, Obstructive
- Obesity
- Hypoventilation
- Obesity Hypoventilation Syndrome
Other Study ID Numbers
- 258045
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Obesity Hypoventilation Syndrome (OHS)
-
Bezmialem Vakif UniversityIstanbul UniversityRecruitingObesity Hypoventilation Syndrome (OHS)Turkey (Türkiye)
-
Wissenschaftliches Institut Bethanien e.VPhilips RespironicsCompletedObesity Hypoventilation Syndrome (OHS)Germany
-
Mayo ClinicCompletedSleep Apnea Syndromes | Sleep Apnea, Obstructive | Obesity Hypoventilation Syndrome (OHS)United States
-
Assiut UniversityCompletedObesity Hypoventilation Syndrome (OHS)Egypt
-
Istituto Auxologico ItalianoUniversity of Florence; Apnimed Inc.; VIS Ethic Research Srl; STM Pharma PRO srlCompletedObesity Hypoventilation Syndrome (OHS)Italy
-
Tyco Healthcare GroupUnknownObesity-Hypoventilation Syndrome (OHS)France
-
Istanbul UniversityCompletedObesity Hypoventilation Syndrome (OHS)Turkey
-
Istanbul University - CerrahpasaNot yet recruitingObesity Hypoventilation Syndrome (OHS)Turkey
-
Fundació Institut de Recerca de l'Hospital de la...WithdrawnObesity Hypoventilation Syndrome (OHS) | Chest Wall Disorders | Neuromuscular DisordersSpain
-
Assiut UniversityNot yet recruitingObesity Hypoventilation Syndrome (OHS)
Clinical Trials on Bariatric Surgery
-
Centre Hospitalier Universitaire de NiceTerminatedObesity | Chronic Kidney DiseaseFrance
-
Imperial College LondonRecruitingObesity | Type 2 DiabetesIreland
-
McMaster UniversityNot yet recruitingRobotic Surgery | Bariatric Surgery
-
Fondazione Policlinico Universitario Agostino Gemelli...Not yet recruiting
-
Chinese University of Hong KongRecruitingLower Urinary Tract Symptoms | Bariatric Surgery CandidateHong Kong
-
Karolinska InstitutetRecruitingCardiovascular Diseases | Bariatric Surgery Candidate | MoralitySweden
-
Queen Fabiola Children's University HospitalNot yet recruitingMorbid Obesity | Adolescent Obesity | Bariatric SurgeryBelgium
-
Rabin Medical CenterRecruiting
-
V.K.V. American Hospital, IstanbulCompletedBariatric Surgery Candidate | Post Operative Pain | Regional Anesthesia MorbidityTurkey